Issue 3

It may not be difficult to diagnose disease caused by crystals, but outside the management of symptomatic hyperuricemia, there are more questions than answers when it comes to crystal disease.

Proof-of-concept trials of dendritic cell immunotherapy have raised interest in their potential as targets for autoimmune disease immunotherapy. Meanwhile, cancer immunotherapy is in clinical use, and rheumatologists are seeing the fallout.

The Hench Memorial Lecture on Tuesday will look back at a journey that began with the discovery of the importance of the adrenal gland by Thomas Addison in 1855 and continues today.

As new treatments emerge for osteoarthritis (OA), it is important for clinicians to understand how and which of these treatments reduce joint pain, and if pain reduction can combine to improve or perhaps worsen joint structure.

Access to medication is an issue for many Americans, even if they have commercial or government health insurance. Availability and affordability are affected by formulary restrictions and increasing patient cost-sharing based on list prices of drugs.

This session will help rheumatology professionals develop a general approach to evaluating arthritis on conventional radiographs and understand the utility and understanding the appropriateness of more advanced imaging modalities.

An ARHP session, Rheumatology 101, is intended to provide the new RN or advanced practice provider (APP) with an overview of rheumatology care to allow them to practice knowledgeably and comfortably.

A western lifestyle has been implicated as contributing to the onset of various inflammatory and autoimmune diseases.

Upon receiving the presidential gavel, Hazel L. Breland, PhD, OTR/L, FAOTA, CLA, will become the 50th ARHP president and the first African-American woman to assume this title.